249 related articles for article (PubMed ID: 36044803)
21. Progression to Symptomatic Multiple Myeloma Predicted by Texture Analysis-Derived Parameters in Patients Without Focal Disease at
Ripani D; Caldarella C; Za T; Rossi E; De Stefano V; Giordano A
Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):536-544. PubMed ID: 33985932
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of bone marrow invasion on the machine learning of 18 F-FDG PET texture analysis in lower gingival squamous cell carcinoma.
Fukushima Y; Suzuki K; Kim M; Gu W; Yokoo S; Tsushima Y
Nucl Med Commun; 2024 May; 45(5):406-411. PubMed ID: 38372047
[TBL] [Abstract][Full Text] [Related]
23. Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.
Peng L; Hong X; Yuan Q; Lu L; Wang Q; Chen W
Ann Nucl Med; 2021 Apr; 35(4):458-468. PubMed ID: 33543393
[TBL] [Abstract][Full Text] [Related]
24. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of baseline
Faudemer J; Aide N; Gac AC; Damaj G; Vilque JP; Lasnon C
Sci Rep; 2021 Dec; 11(1):23812. PubMed ID: 34893676
[TBL] [Abstract][Full Text] [Related]
26. The relationship between immunohistochemical parameters, bone marrow fibrosis and bone marrow
Oner AO; Özdemir Ç; Yavaşoğlu F; Şenol Y; Adsız SN
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(5):289-295. PubMed ID: 36963759
[TBL] [Abstract][Full Text] [Related]
27. Imaging and bone marrow assessments improve minimal residual disease prediction in multiple myeloma.
Alonso R; Cedena MT; Gómez-Grande A; Ríos R; Moraleda JM; Cabañas V; Moreno MJ; López-Jiménez J; Martín F; Sanz A; Valeri A; Jiménez A; Sánchez R; Lahuerta JJ; Martínez-López J
Am J Hematol; 2019 Aug; 94(8):853-861. PubMed ID: 31074033
[TBL] [Abstract][Full Text] [Related]
28. Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials.
Jamet B; Morvan L; Nanni C; Michaud AV; Bailly C; Chauvie S; Moreau P; Touzeau C; Zamagni E; Bodet-Milin C; Kraeber-Bodéré F; Mateus D; Carlier T
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1005-1015. PubMed ID: 33006656
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
[TBL] [Abstract][Full Text] [Related]
30. The added diagnostic value of 18 F-FDG PET/CT radiomic analysis in multiple myeloma patients with negative visual analysis.
An S; Huang G; Yu X; Liu J; Chen Y
Nucl Med Commun; 2024 Mar; 45(3):244-252. PubMed ID: 38165165
[TBL] [Abstract][Full Text] [Related]
31. Potential feature exploration and model development based on 18F-FDG PET/CT images for differentiating benign and malignant lung lesions.
Zhang R; Zhu L; Cai Z; Jiang W; Li J; Yang C; Yu C; Jiang B; Wang W; Xu W; Chai X; Zhang X; Tang Y
Eur J Radiol; 2019 Dec; 121():108735. PubMed ID: 31733432
[TBL] [Abstract][Full Text] [Related]
32. Volumetric and radiomics assessment of lesions with incidental [18F]FDG uptake in the colon: a retrospective radiomics study.
Agüloğlu N; Acar Akkaya E; Binicier ÖB
Q J Nucl Med Mol Imaging; 2023 Jun; 67(2):145-151. PubMed ID: 34664824
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Importance of Bone Marrow Uptake on Baseline
Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
[TBL] [Abstract][Full Text] [Related]
34. Active bone marrow segmentation based on computed tomography imaging in anal cancer patients: A machine-learning-based proof of concept.
Fiandra C; Rosati S; Arcadipane F; Dinapoli N; Fato M; Franco P; Gallio E; Scaffidi Gennarino D; Silvetti P; Zara S; Ricardi U; Balestra G
Phys Med; 2023 Sep; 113():102657. PubMed ID: 37567068
[TBL] [Abstract][Full Text] [Related]
35. A multidomain fusion model of radiomics and deep learning to discriminate between PDAC and AIP based on
Wei W; Jia G; Wu Z; Wang T; Wang H; Wei K; Cheng C; Liu Z; Zuo C
Jpn J Radiol; 2023 Apr; 41(4):417-427. PubMed ID: 36409398
[TBL] [Abstract][Full Text] [Related]
36. Bone Marrow and Tumor Radiomics at
Mattonen SA; Davidzon GA; Benson J; Leung ANC; Vasanawala M; Horng G; Shrager JB; Napel S; Nair VS
Radiology; 2019 Nov; 293(2):451-459. PubMed ID: 31526257
[TBL] [Abstract][Full Text] [Related]
37. Comparison of (11)C-4'-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma.
Okasaki M; Kubota K; Minamimoto R; Miyata Y; Morooka M; Ito K; Ishiwata K; Toyohara J; Inoue T; Hirai R; Hagiwara S; Miwa A
Ann Nucl Med; 2015 Apr; 29(3):224-32. PubMed ID: 25421383
[TBL] [Abstract][Full Text] [Related]
38. Chemokine receptor-4 targeted PET/CT with
Pan Q; Cao X; Luo Y; Li J; Feng J; Li F
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):537-546. PubMed ID: 31776631
[TBL] [Abstract][Full Text] [Related]
39. Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial.
Bodet-Milin C; Morvant C; Carlier T; Frecon G; Tournilhac O; Safar V; Kraeber-Bodere F; Le Gouill S; Macintyre E; Bailly C
Sci Rep; 2023 Oct; 13(1):18177. PubMed ID: 37875524
[TBL] [Abstract][Full Text] [Related]
40. CT radiomics analysis of lung cancers: Differentiation of squamous cell carcinoma from adenocarcinoma, a correlative study with FDG uptake.
Tomori Y; Yamashiro T; Tomita H; Tsubakimoto M; Ishigami K; Atsumi E; Murayama S
Eur J Radiol; 2020 Jul; 128():109032. PubMed ID: 32361604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
